Barclays’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
556,522
+87,351
| +19% | +$302K | ﹤0.01% | 2259 |
|
|
2025
Q1 | $1.23M | Buy |
469,171
+155,969
| +50% | +$409K | ﹤0.01% | 2333 |
|
|
2024
Q4 | $1.29M | Buy |
313,202
+61,383
| +24% | +$253K | ﹤0.01% | 2480 |
|
|
2024
Q3 | $1.78M | Buy |
251,819
+136,541
| +118% | +$967K | ﹤0.01% | 2263 |
|
|
2024
Q2 | $752K | Sell |
115,278
-24,718
| -18% | -$161K | ﹤0.01% | 2279 |
|
|
2024
Q1 | $1.16M | Sell |
139,996
-154,789
| -53% | -$1.28M | ﹤0.01% | 2296 |
|
|
2023
Q4 | $3.25M | Buy |
294,785
+79,316
| +37% | +$873K | ﹤0.01% | 1815 |
|
|
2023
Q3 | $1.81M | Sell |
215,469
-93,710
| -30% | -$788K | ﹤0.01% | 1728 |
|
|
2023
Q2 | $3.88M | Buy |
309,179
+114,709
| +59% | +$1.44M | ﹤0.01% | 1356 |
|
|
2023
Q1 | $3.2M | Sell |
194,470
-77,369
| -28% | -$1.27M | ﹤0.01% | 1341 |
|
|
2022
Q4 | $4.06M | Buy |
271,839
+121,628
| +81% | +$1.82M | ﹤0.01% | 1226 |
|
|
2022
Q3 | $3.36M | Buy |
150,211
+80,404
| +115% | +$1.8M | ﹤0.01% | 1324 |
|
|
2022
Q2 | $1.17M | Sell |
69,807
-6,261
| -8% | -$105K | ﹤0.01% | 1944 |
|
|
2022
Q1 | $2.28M | Buy |
+76,068
| New | +$2.28M | ﹤0.01% | 1686 |
|